基于仪器的筛查用于检测弱视及弱视危险因素:美国眼科学会报告
本报告系统综述了基于仪器的筛查设备检测弱视及弱视危险因素的诊断准确性,纳入33项研究、共28072名儿童,证据等级均为III级。常用设备包括Plusoptix、Spot和Retinomax,检测弱视危险因素的敏感度范围为32.3%至100%,特异度范围为38.7%至94%。结论认为现有最佳证据支持使用基于仪器的筛查设备,但研究设计、场景和目标年龄异质性高。
要点
- 33项研究共28072名儿童,证据等级均为III级,多数研究聚焦6岁及以下儿童。
- 检测弱视危险因素敏感度32.3%-100%,特异度38.7%-94%,因设备不同而异。
- 转诊率在报告该指标的21项研究中变异大(2.26%-63%),眼科诊所研究转诊率更高。
核心结论
- 现有最佳证据支持使用基于仪器的筛查设备检测弱视及弱视危险因素。
- 研究设计、筛查场景和目标年龄存在高度异质性,诊断准确性因所用筛查设备而异。
- 未来研究应遵循诊断准确性的标准化报告措施,以加强证据基础并为筛查方案决策提供更完整数据。
研究设计与样本
- 美国眼科学会(American Academy of Ophthalmology)报告,通过PubMed数据库检索截至2025年1月的英文文献,无日期限制。
- 检索获得291篇文章,41篇全文审阅,33篇符合纳入标准。
- 方法学家对每项纳入研究进行证据等级评定,33篇均评为III级,共报告28072名儿童的结果。
主要发现
- 共讨论9种筛查设备,最常见为Plusoptix、Spot和Retinomax。
- 多数研究聚焦6岁及以下儿童,最常见研究场景为眼科诊所,其次为学校场景和社区场景。
- 检测弱视危险因素总体敏感度32.3%-100%,特异度38.7%-94%。
- Plusoptix敏感度32.3%-100%、特异度38.7%-100%;Retinomax敏感度70%-95%、特异度58%-94%;Spot敏感度60%-94%、特异度67%-97%。
- 21项研究报告转诊率(筛查结果未通过儿童百分比),范围为2.26%-63%,眼科诊所研究转诊率更高。
关键数值与推荐
- 检查失败阈值各异,但2013年之后多数研究遵循2013年美国小儿眼科学与斜视协会(AAPOS)指南。
- 检测弱视危险因素:Plusoptix敏感度32.3%-100%、特异度38.7%-100%;Retinomax敏感度70%-95%、特异度58%-94%;Spot敏感度60%-94%、特异度67%-97%。
- 21项报告转诊率的研究中,转诊率范围为2.26%-63%。
临床怎么用
- 现有最佳证据支持使用基于仪器的筛查设备检测弱视及弱视危险因素。
- 诊断准确性因所用筛查设备而异,研究设计、场景和目标年龄存在高度异质性。
- 未来研究应遵循诊断准确性的标准化报告措施,以加强证据基础并为最合适筛查方案和策略的决策提供更完整数据。
局限性
- 纳入研究在设计、场景和目标年龄方面存在高度异质性。
- 诊断准确性因所用筛查设备而异。
- 未来研究应遵循诊断准确性的标准化报告措施,以加强证据基础并为筛查方案决策提供更完整数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To review the published literature on the diagnostic accuracy of instrument-based screening devices used to detect amblyopia and amblyopia risk factors (ARFs). METHODS: A literature search of the PubMed database with no date restrictions and limited to articles published in English was last conducted in January 2025. The search yielded 291 articles; 41 were reviewed in full text, and 33 met the criteria for inclusion in this assessment. The panel methodologist assigned a level of evidence rating to each of the included studies. RESULTS: All 33 articles (which reported results from 28 072 children) were rated level III. Nine screening devices were discussed in the included studies; the most common were the Plusoptix, Spot, and Retinomax. Results from 28 072 children were reported, and most studies focused on children aged 6 years and younger. The most common study setting was ophthalmology clinics, followed by school-based settings and then community-based settings. For detecting ARFs, sensitivity ranged from 32.3% to 100% and specificity ranged from 38.7% to 94% (Plusoptix sensitivity 32.3%-100%, specificity 38.7%-100%; Retinomax sensitivity 70%-95%, specificity 58%-94%; Spot sensitivity 60%-94%, specificity 67%-97%). Examination failure thresholds varied, but most studies after 2013 followed the 2013 American Association for Pediatric Ophthalmology and Strabismus (AAPOS) guidelines. For the 21 studies that reported the referral rate (percentage of children who failed based on the screening result), the rate varied significantly (2.26%-63%). Higher referral rates were seen in studies based in ophthalmology clinics. CONCLUSIONS: The best available evidence supports the use of instrument-based screening devices to detect amblyopia and ARFs, although there were high levels of variability in the study design, setting, and target age for screening. Additionally, diagnostic accuracy varied on the basis of the screening device used. Future studies of instrument-based screening devices would benefit from following standardized reporting measures for diagnostic accuracy, which will strengthen the evidence base and provide more complete data on which to base decisions about the most appropriate screening programs and strategies. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
引用
- Oatts JT, Collins ME, Cavuoto KM, et al. Instrument-Based Screening for the Detection of Amblyopia and Amblyopia Risk Factors: A Report by the American Academy of Ophthalmology. Ophthalmology. 2025. PMID: 40864029. doi:10.1016/j.ophtha.2025.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。